Population Pharmacokinetic Analysis to Support and Facilitate Switching from Risperidone Formulations to Rykindo in Patients with Schizophrenia.
Saved in:
| Title: | Population Pharmacokinetic Analysis to Support and Facilitate Switching from Risperidone Formulations to Rykindo in Patients with Schizophrenia. |
|---|---|
| Authors: | Wang W; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, China. wangwenyan@ytu.edu.cn.; Research and Development Center, Luye Pharma, Yantai, Shandong, China. wangwenyan@ytu.edu.cn.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Yantai, Shandong, China. wangwenyan@ytu.edu.cn., Wang X; ClinPharm Solutions LLC, Chester, NJ, USA., Dong Y; Global Clinical Development, Luye Pharma (US), Ltd., Princeton, NJ, USA., Walling DP; CenExel-CNS, Garden Grove, CA, USA., Liu P; Research and Development Center, Luye Pharma, Yantai, Shandong, China.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Yantai, Shandong, China., Liu W; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, China.; Research and Development Center, Luye Pharma, Yantai, Shandong, China.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Yantai, Shandong, China., Shi Y; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, China.; Research and Development Center, Luye Pharma, Yantai, Shandong, China.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Yantai, Shandong, China., Sun K; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, Shandong, China. sunkx@ytu.edu.cn.; Research and Development Center, Luye Pharma, Yantai, Shandong, China. sunkx@ytu.edu.cn.; National Key Laboratory of Advanced Drug Delivery and Release Systems, Yantai, Shandong, China. sunkx@ytu.edu.cn. |
| Source: | Neurology and therapy [Neurol Ther] 2024 Apr; Vol. 13 (2), pp. 355-372. Date of Electronic Publication: 2024 Jan 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: New Zealand NLM ID: 101637818 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8253 (Print) Linking ISSN: 21936536 NLM ISO Abbreviation: Neurol Ther Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2193-8253 |
|---|---|
| DOI: | 10.1007/s40120-024-00578-w |
